Denali Therapeutics Email Format

Biotechnology Research
501-1,000 employees
South San Francisco, CA, USA

Denali Therapeutics is a biotechnology company developing biotherapeutics designed to cross the blood-brain barrier for neurodegenerative and lysosomal storage diseases.

Find contacts at Denali Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

last@dnli.com

Company Overview

Industry
Biotechnology Research
Founded
2015
Headquarters
South San Francisco, CA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Key Executives
Ryan Watts (Chief Executive Officer), Alexander Schuth (Chief Operating and Financial Officer), Dana Andersen, Ph.D. (Chief Technical and Manufacturing Officer)

Tech Stack

Amazon Web Services

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Denali Therapeutics?

Denali Therapeutics uses the last format, so Jane Smith would be smith@dnli.com.

What is Denali Therapeutics' first FDA-approved product?

Denali Therapeutics received FDA accelerated approval on March 25, 2026 for AVLAYAH (tividenofusp alfa-eknm), a therapy for the neurologic manifestations of Hunter syndrome (MPS II) and the first biologic engineered to cross the blood-brain barrier via its proprietary TransportVehicle platform.

How does Denali Therapeutics' TransportVehicle platform work?

Denali Therapeutics' TransportVehicle platform is a proprietary technology that ferries large therapeutic molecules such as enzymes, antibodies, and oligonucleotides across the blood-brain barrier. It includes three variants: the Enzyme TransportVehicle (ETV), Oligonucleotide TransportVehicle (OTV), and Antibody TransportVehicle (ATV).

Who co-founded Denali Therapeutics and currently leads the company?

Ryan Watts, Ph.D. co-founded Denali Therapeutics and serves as its CEO and President. He also sits on the company's Board of Directors and was previously a director at Genentech before starting Denali.

Where can I find and verify a Denali Therapeutics contact's email address?

Since Denali Therapeutics uses the last-name-only format on the dnli.com domain, you can build an address by taking the person's surname and appending @dnli.com. Tools like Clay can help you verify these addresses and enrich your prospect list with additional contact details for the company's 575-person team.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles